Syncona Shares News & Articles

Autolus IPO gives welcome lift to Neil Woodford's under pressure Patient Capital Trust

Investment trusts Woodford Patient Capital (WPCT) and Syncona (SYNC) get a major boost as the initial public offering (IPO) of portfolio company Autolus was priced at the top of the $15 to $17 range. Autolus is a gene therapy developer at the cutting edge of cancer treatment. It is working on Chimeric Antigen Receptor therapies for white blood cells called T-cells, or CAR-T therapies. The ...
Showing 1 to 9 of 9